RxDoctor Payments Data

Seth Howard

Family · Mesa, AZNPI 1700529690

Payments from drug & device makers

$3,698in general payments, 2019–2025

Across 85 payments — averaging $43.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AOP Health US, LLC$942
  • Novartis$567
  • Impulse Dynamics (USA) Inc.$448
  • Medtronic$311
  • Sanofi-aventis U.S. LLC$283
  • Boston Scientific$269
  • plus $878 from 17 others

What the payments were for

  • Food & beverage$3,66099%
  • Other$391%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,698 in reported general payments places this provider in the 90th percentile of 4,119 family providers in Arizona.

See all family providers in Arizona

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban174$227,511
EntrestoSacubitril/Valsartan52$80,850
XareltoRivaroxaban53$66,900
Repatha SureclickEvolocumab36$47,449
FarxigaDapagliflozin Propanediol19$19,078
BrilintaTicagrelor11$11,404
Metoprolol Succinate201$2,898
Losartan Potassium194$1,895
Rosuvastatin Calcium110$1,465
Ezetimibe38$1,453
Irbesartan60$1,386
Atorvastatin Calcium137$1,368
Isosorbide Mononitrate ErIsosorbide Mononitrate76$1,277
Metoprolol Tartrate190$1,226
Amiodarone Hcl67$1,210

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$45$227,511174 claims
NovartisEntresto$567$80,85052 claims
AstraZenecaFarxiga, Brilinta$48$30,48130 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,119 family providers in Arizona.

Other family in Mesa

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →